DUBLIN, December 2, 2015 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/9zknb5/global_diabetes) has announced the addition of the "Global Diabetes Care Devices Market Outlook: 2015-2020" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
The global diabetes care devices market is expected to grow at a CAGR of 5.2% from 2015 to 2020 to reach $24.6 billion by 2020
This market is mainly driven by increasing prevalence of diabetes, technological advancements, rise in obese population, sedentary lifestyle and improper diet, and increasing need for faster and safer diagnosis and treatment of diabetes. Furthermore, huge investments by the market leaders and foraying of new companies into this market, wide scope of penetration in untapped and emerging markets, and rising awareness among people about diabetes care are also accelerating the growth of this market. However, high cost associated with diagnosis and treatment, reimbursement issues for new technologies, lack of awareness, strict regulatory obligations, and high cost of diabetic food hinders the growth of this market to some extent.
The research report on the diabetes care devices market provides comprehensive analysis of the global market with a country level analysis and helps in understanding the driving forces for the growth of this market. The report also provides analysis of major product segments such as diabetes control solutions, diabetes monitoring devices, and insulin delivery devices. The diabetes monitoring devices segment further sub-segmented into continuous blood glucose monitoring devices, test strips, lancets, and hemoglobin A1c (HbA1c) testing kits. The insulin delivery devices further sub-segmented into insulin syringes, insulin pens, insulin pumps, and insulin injectors.
The global diabetes care devices market is mainly dominated by Roche Diagnostics with its Accu Chek line of products and followed by Johnson & Johnson with its subsidiaries LifeScan, Inc. and Animas Corporation having robust portfolio of diabetes care products such as OneTouch Ultramini, Animas Vibe, and Onetouch Verio in 2014. Novo Nordisk and Eli Lilly and Company have been the market leaders in insulin delivery devices market, especially in insulin pens.
Along with Roche and Johnson and Johnson, Bayer AG and Abbott Laboratories also has a strong presence in the growing markets for diabetes care devices such as India and China with Bayer AG contributing 5-10% share in the Indian diabetes care devices market in 2014. The other key players in the global diabetes care devices market are, Ypsomed AG, Medtronic plc, Becton, Dickinson and Company, Acon Laboratories, Inc., Alere Inc., ARKRAY Inc., Terumo Corporation, Dexcom, Inc. (U.S.), Siemens AG, Tandem Diabetes Care, Inc., Owen Mumford Ltd., and Sanofi S.A.
Key Topics Covered:
1 Introduction to Diabetes Care Devices Market
2 Executive Summary
3 Market Insights
4 Global Diabetes Care Devices- Market Crackdown ($ Value Analysis), By Product Type
5 Diabetes Care Devices- Market Crackdown ($ Value Analysis), By Geography
6 Global Diabetes Care Devices Market- Competitive Landscape
7 Company Profiles
- ARKRAY Inc.
- Abbott Laboratories
- Bayer HealthCare AG
- Becton, Dickinson and Company
- Dexcom, Inc.
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson
- Medtronic, Inc.
- Novo Nordisk A/S
- Sanofi S.A
- Tandem Diabetes Care, Inc
- Terumo Corporation
- Ypsomed AG
For more information visit http://www.researchandmarkets.com/research/9zknb5/global_diabetes
About Research and Markets:
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Laura Wood
+353-1-481-1716
press@researchandmarkets.net
Share this article